|
Location of NTM infections | Total cases | Etiology | Medical treatment | Surgical treatment | Outcomes |
|
Orbital infections | 11 | (i) Orbital reconstruction/Fracture repair 4/11 (36.4%) (ii) Orbital Implant 5/11 (45.5%) | Systemic ATB combination (>2 ATB) 6/11 (54.6%) | Excision of lesion 3/11 (37.5%) | (i) Resolution 7/10 (70%) (ii) VA of 20/200 or worse 3/10 (30%) (iii) Prolonged course 4/10 (40%) |
|
Eyelid/periocular skin infections | 28 | (i) Ptosis Repair and/or Blepharoplasty 22/28 (78.6%) (ii) Implants 9/28 (32.1%) | Systemic ATB combination (>2 ATB) 14/28 (50%) | (i) Excision/incision and drainage/debridement 13/28 (46.4%) (ii) Removal of implant 7/28 (25%) | (i) Resolution 22/28 (78.5%) (ii) Prolonged course 6/28 (21.4%) |
|
Lacrimal system infections | 17 | (i) Implants 13/17 (76.5%) (ii) Punctal Plug or Lacrimal Tube Insertions 9/17 (52.9%) (iii) DCR +/− stent placement 5/17 (29.4%) | Topical + systemic 7/17 (41.2%) | Removal of implant 10/17 (58.8%) | (i) Resolution 13/17 (76.5%) (ii) Prolonged course 3/17 (17.6%) |
|
Keratitis | 290 | (i) LASIK 130/273 (47.6%) (ii) Trauma 43/264 (14.8%) (iii) Foreign body 51/211 (17.6%) (iv) Contact lenses 19/276 (6.4%) (v) Implants 44/254 (17.3%) | (i) Topical 108/203 (53.2%)* (ii) Topical + systemic 85/203 (41.9%)* | (i) Removal of corneal flap 49/283 (17.3%) (ii) PKP 40/283 (14.1%) | (i) Resolution 190/235 (80.9%) (ii) VA 20/40 or better 112/204 (54.9%) (iii) VA of 20/200 or worse 40/204 (19.6%) |
|
Scleritis | 18 | Scleral buckling 14/18 (77.8%) | Topical 16/17 (94.1%) | Explanation of buckle 13/17 (76.5%) | (i) Resolution 16/17 (94.1%) (ii) VA of 20/200 or worse 10/14 (71.4%) |
|
Endophthalmitis | 44 | Cataract surgery (IOL insertion) 18/37 (48.6%) | (i) Intraocular + topical/systemic/periocular 14/38 (36.8%) (ii) Intraocular 5/38 (13.2%) | PPV 13/37 (35.1%) | (i) Resolution 12/36 (33.3%) (ii) Loss of eye 12/36 (33.3%) (iii) Loss of vision 12/36 (33.3%) |
|
Uveitis | 9 | HIV/AIDS 5/9 (55.6%) | Systemic/topical + systemic 6/9 (66.7%) | (i) PPV 1/8 (12.5%) (ii) Evisceration 1/8 (12.5%) (iii) Enucleation 1/8 (12.5%) | (i) Resolution 4/9 (44.4%) (ii) Loss of eye 3/9 (33.3%) (iii) VA 20/40 or better 2/4 (50%) |
|